A need to continually assess the design of current and future research …

• Abstract
• Patient autonomy
• Bemeficence
• Non-maleficence
• Distributive justice
• Conclusions
• References

REFERENCES
Beauchamp TL, Childress JF. Principles of biomedical ethics, 5th edn. New York: Oxford University Press 1988:1–546. Montaner JS, O’Shaughnessy MV, Schechter MT. Industry-sponsored clinical research: a double-edged sword. Lancet 2001;358:1893–5. Bodenheimer T . Uneasy alliance: clinical investigators and the pharmaceutical industry. N Engl J Med 2000;342:1539–44. Kahn JP, Mastroianni AC. Moving from compliance to conscience; why we can and should improve the ethics of clinical research. Arch Intern Med 2001;161:925–8. Djulbegovic B, Lacevic M, Cantor A, Fields KK, Bennett CL, Adams JR, et al. The uncertainty principle and industry-sponsored research. Lancet 2000;356:635–8. Montori VM, Smieja M, Guyatt GH. Publication bias: a brief review for clinicians. Mayo Clin Proc 2000;75:1284–8. Rothman KJ, Michels KB. The continuing unethical use of placebo controls. N Engl J Med 1994;331:394–8. Kleijnen J, de Craen AJ, van Everdingen J, Krol L. Placebo effect in double-blind clinical trials: a review of interactions with medications. Lancet 1994;344:1347–9. Stein CM, Pincus T. Placebo-controlled trials in rheumatoid arthritis: ethical issues. Lancet 1999;353:400–3. Hill AB. Medical ethics and controlled trials. BMJ 1963;i:1043–9. Lewis JA, Jonsson B, Kreutz G, Sampaio C, van Zwieten-Boot B. Placebo controlled trials and the Declaration of Helsinki. Lancet 2002;359:1337–40. The World Medial Association. www.wma.net/e/ (accessed 24 Sept 2004). Shapiro H, Meslin E. Ethical issues in the design and conduct of clinical trials in developing countries. N Engl J Med 2001;345:139–42. Forster HP, Emanuel E, Grady C. The 2000 revision of the Declaration of Helsinki: a step forward or more confusion? Lancet 2001;358:1449–53.